99% Savings - Buy Just @1 Rs X
Microcef Cv is a prescription drug, available for use as Syrup, Tablet. The alternative uses of Microcef Cv have also been explained below.
The optimal dosage of Microcef Cv is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Microcef Cv side effects, there are can be others also. These have been listed below. Such side effects of Microcef Cv normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Microcef Cv is Mild for pregnant women and Moderate for women who are breastfeeding. Further, the section on Microcef Cv related warnings talks about Microcef Cv's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Microcef Cv since this can cause severe adverse effects. Other contraindications of Microcef Cv have been discussed in the sections ahead.
Drug interactions for Microcef Cv have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Microcef Cv is considered safe while driving, and is addictive.
Microcef Cv is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Microcef Cv safe for pregnant women?
Pregnant women may get mild side effects from Microcef CV.
Is the use of Microcef Cv safe during breastfeeding?
Microcef CV may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Microcef CV, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Microcef CV.
What is the effect of Microcef Cv on the Kidneys?
Microcef CV can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Microcef Cv on the Liver?
There may be an adverse effect on the liver after taking Microcef CV. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Microcef Cv on the Heart?
Microcef CV may have mild side effects on the heart. Most people will never see any effect on the heart.
Microcef Cv should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Microcef Cv unless your doctor advises you to do so -
Is this Microcef Cv habit forming or addictive?
Microcef Cv is not addictive in nature.
Interaction between Food and Microcef Cv
It is safe to take Microcef Cv with food.
Interaction between Alcohol and Microcef Cv
It is difficult to say anything about the effect of Microcef Cv and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311